PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, Geelong, Victoria, Australia.\', \'Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.\', \'Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, Victoria, Australia.\', \'School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.\', \'Infection Prevention and Healthcare Epidemiology Unit, Alfred Health, Melbourne, Victoria, Australia.\', \'Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan.\', \'Department of Health Sciences, University of York, York, United Kingdom.\', \'Exios Bio LLC, Conshohocken, Pennsylvania, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.ppat.1009759
?:hasPublicationType
?:journal
  • PLoS pathogens
is ?:pmid of
?:pmid
?:pmid
  • 34320031
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.006
?:rankingScore_hIndex
  • 154
is ?:relation_isRelatedTo_publication of
?:title
  • Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all